"Atenolol" - Books

Result Filters

Results: 1 to 20 of 193 books (782 items)

<< First< Prev

Page of 10

Next >Last >>

Select item 26591821.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].

York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Top results in this book Table of Contents

Select item 44036682.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2026 Jan-.

Top results in this book Table of Contents

Select item 48538163.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

Top results in this book Table of Contents

Select item 42079044.

Diagnosis and Management of Infantile Hemangioma [Internet].

Chinnadurai S, Snyder K, Sathe N, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan. (Comparative Effectiveness Reviews, No. 168.)

Top results in this book Table of Contents

Select item 34012945.

Endotext [Internet].

Feingold KR, Adler RA, Ahmed SF, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

Top results in this book Table of Contents

Select item 52977146.

Evidence review for postnatal management of hypertension: Hypertension in pregnancy: diagnosis and management: Evidence review E.

National Guideline Alliance (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 Jun. (NICE Guideline, No. 133.)

Top results in this book Table of Contents

Select item 45657287.

Drugs and Lactation Database (LactMed®) [Internet].

Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Top results in this book Table of Contents

Select item 56795208.

Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling.

Mistry H, Naghdi S, Brown A, et al.

Southampton (UK): National Institute for Health and Care Research; 2024 Oct. (Health Technology Assessment, No. 28.63.)

Top results in this book Table of Contents

Select item 52976529.

Evidence review for interventions for chronic hypertension: Hypertension in pregnancy: diagnosis and management: Evidence review A.

National Guideline Alliance (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 Jun. (NICE Guideline, No. 133.)

Top results in this book Table of Contents

Select item 554283210.

Therapeutics Letter.

Perry T, editor.

Vancouver (BC): Therapeutic Initiatives; 1994-.

Top results in this book Table of Contents

Select item 227434411.

Drug Treatments for the Prevention of Migraine Headache.

Gray RN, Goslin RE, McCrory DC, et al.

Rockville (MD): Agency for Health Care Policy and Research (US); 1999 Feb. (Technical Reviews, No. 2.3.)

Top results in this book Table of Contents

Select item 535251012.

MotherToBaby | Fact Sheets [Internet].

Brentwood (TN): Organization of Teratology Information Specialists (OTIS); 1994-.

Top results in this book Table of Contents

Select item 512179013.

Evidence review for beta-blockers: Acute coronary syndromes: Evidence review H.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2020 Nov. (NICE Guideline, No. 185.)

Top results in this book Table of Contents

Select item 529841414.

Evidence review for step 1 treatment: Hypertension in adults: diagnosis and management: Evidence review E.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 Aug. (NICE Guideline, No. 136.)

Top results in this book Table of Contents

Select item 165969415.

Disease Control Priorities in Developing Countries. 2nd edition.

Jamison DT, Breman JG, Measham AR, et al., editors.

Washington (DC): The International Bank for Reconstruction and Development / The World Bank; New York: Oxford University Press; 2006.

Top results in this book Table of Contents

Select item 261955016.

Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension: An Update [Internet].

Sanders GD, Coeytaux R, Dolor RJ, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Jun. (Comparative Effectiveness Reviews, No. 34.)

Top results in this book Table of Contents

Select item 437588217.

Benefits and Harms of Treating Blood Pressure in Older Adults: A Systematic Review and Meta-analysis [Internet].

Weiss J, Kerfoot A, Freeman M, et al.

Washington (DC): Department of Veterans Affairs (US); 2016 Apr.

Top results in this book Table of Contents

Select item 489291018.

Addendum to Clinical Guideline 150, Headaches in over 12s: diagnosis and management.

London: National Institute for Health and Care Excellence (NICE); 2015 Nov. (Clinical Guideline Addendum, No. 150.1.)

Top results in this book Table of Contents

Select item 512184019.

Evidence review for antithrombin therapy in adults with ST-segment elevation myocardial infarction intended for primary percutaneous coronary intervention: Acute Coronary Syndromes: Evidence review D.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2020 Nov. (NICE Guideline, No. 185.)

Top results in this book Table of Contents

Select item 160688420.

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

National High Blood Pressure Education Program.

Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2004 Aug.

Top results in this book Table of Contents

<< First< Prev

Page of 10

Next >Last >>

Supplemental Content

Images search in Bookshelf

FIGURE 14.4

Propranolol pretreatment inhibits yohimbine induced thirst and sodium appetite, but has no effect on furo/cap induced thirst and sodium appetite. Top: rats were given injections of either the β-adrenergic receptor antagonist propranolol (10 mg/kg, IP), which crosses the blood–brain barrier, or the β-adrenergic receptor antagonist atenolol (10 mg/kg, IP), which does not cross the blood–brain barrier, before receiving yohimbine (3 mg/kg, SC). Only propranolol significantly reduced water and sodium intakes, suggesting a role for central β receptors in stress-induced sodium intake (*p < 0.05, Dunn’s post-test after significant ANOVA on ranks). Bottom: rats were given furo/cap injections to exhibit rapid need-induced intake. Pretreatment with propranolol had no significant effect on thirst or sodium appetite.

Sodium Appetite Sensitization.

De Luca LA Jr, Menani JV, Johnson AK, editors. Neurobiology of Body Fluid Homeostasis: Transduction and Integration. Boca Raton (FL): CRC Press/Taylor & Francis; 2014.
Figure 249Beta-blocker vs. placebo - reinfarction (people who have had an MI and who have been initiated with treatment within 72 hours)

Heterogeneity was detected at <6 months, I²=68% and 0-12 months, I2=64%. Investigating factors to ascertain whether they explain the heterogeneity is difficult because in some of the papers it is unclear what the patients LV function status was, ethnicity and age range. In the <6month data, the study by Van De Werf used a low lipid soluble beta-blocker (Atenolol), the others were moderate to highly soluble, but removing it had no effect on heterogeneity. In the 0-12m data, both studies used low lipid soluble beta-blockers and acute treatment was likely to be similar given they were published in the early 1980s. Heterogeneity in both sets of data is likely to be the result of few events recorded and low patient numbers in some of the studies. At 0-12 m if the study by Tonkin et al. was removed, heterogeneity is no longer present. Since heterogeneity could not be explained the results are presented as random effects, rather than fixed effects.

Forest plots.

National Clinical Guideline Centre (UK). MI - Secondary Prevention: Secondary Prevention in Primary and Secondary Care for Patients Following a Myocardial Infarction: Partial Update of NICE CG48 [Internet]. London: Royal College of Physicians (UK); 2013 Nov.